An In Vitro 3D Model and Computational Pipeline to Quantify the Vasculogenic Potential of iPSC-Derived Endothelial Progenitors
May 13th, 2019
Endothelial progenitors derived from induced pluripotent stem cells (iPSC-EPs) have the potential to revolutionize cardiovascular disease treatments and to enable the creation of more faithful cardiovascular disease models. Herein, the encapsulation of iPSC-EPs in three-dimensional (3D) collagen microenvironments and a quantitative analysis of these cells’ vasculogenic potential are described.
Overview
This article discusses the encapsulation of endothelial progenitors derived from induced pluripotent stem cells (iPSC-EPs) in three-dimensional collagen microenvironments. It highlights the potential of these cells in revolutionizing cardiovascular disease treatments and creating more accurate disease models.
Key Study Components
Area of Science
- Cardiovascular disease
- Stem cell research
- Vasculogenesis
Background
- Endothelial progenitors are crucial for vascular development.
- Induced pluripotent stem cells (iPSCs) can differentiate into various cell types.
- 3D microenvironments can enhance cell functionality.
- Understanding vasculogenesis is vital for therapeutic applications.
Purpose of Study
- To analyze the vasculogenic potential of iPSC-EPs.
- To develop a protocol for creating 3D vascular networks.
- To provide a computational pipeline for network analysis.
Methods Used
- Cell detachment solution application for cell harvesting.
- Single-cell suspension preparation for analysis.
- Fluorescence labeling of cells for identification.
- Quantitative analysis of vascular network topology.
Main Results
- Successful encapsulation of iPSC-EPs in 3D collagen matrices.
- Demonstrated vasculogenic potential of the encapsulated cells.
- Established a robust method for evaluating vascular networks.
- Provided an open-source computational tool for analysis.
Conclusions
- iPSC-EPs can be effectively used to model cardiovascular diseases.
- The developed protocol enhances understanding of vasculogenesis.
- This research paves the way for future therapeutic applications.
Frequently Asked Questions
Executive Industry Relevance
Quantifying the vasculogenic potential of iPSC-derived endothelial progenitors in a 3D environment addresses a critical gap in early-stage vascular target validation and disease modeling. The integration of a computational pipeline for network analysis enhances predictive confidence and standardization in preclinical vascular research. This approach supports risk-adjusted portfolio decisions for regenerative and cardiovascular therapeutic programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables rigorous assessment of iPSC-EP vasculogenic function in physiologically relevant 3D matrices.
- Supports mechanistic de-risking by quantifying network formation and connectivity metrics.
- Facilitates comparative evaluation of different progenitor sources or biomaterial platforms.
- Provides objective data for functional target validation in vascular biology.
Screening & Assay Development
- Establishes a reproducible 3D assay system for evaluating endothelial progenitor performance.
- Delivers quantitative outputs such as branch number, branching points, and network length.
- Enables standardization and scalability for compound or biomaterial screening workflows.
- Supports downstream integration with open-source computational analysis tools.
Translational & Preclinical Research
- Aligns in vitro vascular network formation with disease-relevant tissue modeling needs.
- Provides continuity from discovery-stage functional assays to preclinical validation of regenerative strategies.
- Enables risk-adjusted advancement of vascular cell therapies based on quantitative network metrics.
- Supports biomarker development by correlating network topology with functional outcomes.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical research by providing a standardized, quantitative workflow for assessing vasculogenic potential in 3D systems.
- Discovery Biology: Supports hypothesis testing on progenitor cell function and ECM interactions.
- Screening: Delivers reproducible, quantitative readouts for network formation and complexity.
- Analytics: Utilizes computational tools to extract objective network topology metrics.
- Translational Research: Facilitates alignment of in vitro findings with preclinical vascularization goals.
- Enterprise Reuse: Offers an open-source, adaptable pipeline for diverse vascular modeling applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in vascular target validation and mechanistic studies.
- Operational Value: Enhances assay standardization, reproducibility, and scalability across teams.
- Strategic Value: Improves go/no-go decisions for vascular and regenerative medicine programs.
- Portfolio Impact: Enables risk-adjusted prioritization of cell therapy and biomaterial candidates.
Implementation Considerations
- Requires expertise in iPSC culture, FACS, and 3D hydrogel systems.
- Needs access to confocal imaging and computational analysis infrastructure.
- Demands cross-team standardization of cell sorting and imaging protocols.
- Adaptable to various progenitor sources and ECM-mimicking biomaterials.
- Dependent on robust image processing and network quantification workflows.
Biopharma FAQs
Chapters in this video
0:04
Title
0:32
Fluorescence-Activated Cell Sorting (FACS) of Endothelial Progenitors
2:08
Induced Pluripotent Stem Cell-Endothelial Progenitor (iPSC-EP)-Laden Collagen Hydrogel Encapsulation and Long-Term Culture
3:29
EP-Based Vascular Network Visualization
5:22
Results: Representative iPSC-EP Vascular Network Generation and Analysis
6:06
Conclusion
